Om

Crealogix Holding AG, a software company, provides software solutions in Switzerland, rest of Europe, and internationally. The company offers CREALOGIX Digital Hub, a digital engagement platform that enables to accelerate the digitalization of products and services; CREALOGIX Conversational AI, which delivers next-generation customer interaction for financial institutions; and CREALOGIX Funding Portal, an integrated digital funding portal that enables to digitalize the funding process from application to payout. It also provides hosting solutions and data center services. The company serves wealth management, retail banking, corporate banking, SME banking, and public serctors. Crealogix Holding AG was founded in 1996 and is headquartered in Zurich, Switzerland. Crealogix Holding AG operates as subsidiary of Vencora UK Limited.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I NUREXONE BIOLOGIC MED ENDAVU: Køb NurExone Biologic ($NRX) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i NurExone Biologic, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.